Through savings and cash captures generated by a federal drug discount program, safety net facilities are helping ensure low-income patients can access health care services.

But pharmaceutical manufacturers say the discount program, the 340B Drug Pricing Program, has grown well beyond its original scope and is distorting drug pricing in the market at large. They have been pressing particularly hard in recent years to have eligibility rules tightened and participation curtailed.

Were that to happen, according to a May report from the nonprofit membership organization 340B Health, it is unlikely these safety net facilities could offer the same level of health care and the same access to medications for poor patients that they do today. The report is “340B Program Helps Hospitals Provide Services to Vulnerable Patients.”

Read More

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields